Aiko Yamaguchi

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Mesenchymal Stem Cells

Epidermal Growth Factor Receptor

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Yasuaki Anami, Wei Xiong, Aiko Yamaguchi, Chisato M Yamazaki, Ningyan Zhang, Zhiqiang An, Kyoji Tsuchikama
Homogeneous antibody-angiopep 2 conjugates for effective brain targeting. RSC advances 12 (6) (2022)
Chisato M Yamazaki, Aiko Yamaguchi, Yasuaki Anami, Wei Xiong, Yoshihiro Otani, Jangsoon Lee, Naoto Tada Ueno, Ningyan Zhang, Zhiqiang An, Kyoji Tsuchikama
Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance. Nature communications 12 (1) (2021)
Yogi Umbarawan, Ryo Kawakami, Mas Rizky A A Syamsunarno, Hideru Obinata, Aiko Yamaguchi, Hirofumi Hanaoka, Takako Hishiki, Noriyo Hayakawa, Norimichi Koitabashi, Hiroaki Sunaga, Hiroki Matsui, Masahiko Kurabayashi, Tatsuya Iso
Reduced Fatty Acid Use from CD36 Deficiency Deteriorates Streptozotocin-Induced Diabetic Cardiomyopathy in Mice. Metabolites 11 (12) (2021)